Funding Round attributes
Solstice Health, a life sciences marketing engine focused on improving the efficiency of biopharma marketing, has announced the successful completion of a $3.5 million seed funding round. The investment, led by Twelve Below and Virtue, will support the continued development and expansion of Solstice’s AI-powered platform designed to streamline the content supply chain for biopharma marketing teams.
The newly launched platform leverages advanced generative AI to enhance the medical-legal-regulatory (MLR) review process, a crucial yet often time-consuming step in biopharma marketing. The MLR process ensures that promotional content adheres to regulatory standards before it can be distributed, a necessity in the highly regulated pharmaceutical industry. Solstice’s AI-driven approach aims to mitigate inefficiencies by flagging compliance risks early and expediting approval workflows, reducing content evaluation cycle times by an estimated 74%.
Ryan Slipakoff, former Chief Transformation Officer at Klick Health, underscored the significance of solving delays in the MLR review process. “The MLR review process is the biggest choke point in the content supply chain for life science companies,” he stated. “Solving for the time, throughput, and cycle reduction of the current system requires an in-depth understanding of the needs and operating realities of all users, including agencies, marketers, and reviewers. Solstice’s platform is built based on a clear and strong foundation of actual users and operators, offering innovation based on the practical reality of how users will need to use the platform.”
Elaine Kang, Director of Marketing at SpringWorks Therapeutics, expressed optimism about the platform’s impact. “Solstice is transforming the medical-legal-regulatory review process with its AI engine,” she said. “By flagging risks early and ensuring first-pass approval readiness, Solstice enables marketers and review teams to focus on high-impact, strategic decisions rather than manual checks. I’m proud to be part of this journey with the team as they redefine how compliance and speed to market can go hand in hand.”
Solstice’s AI-powered MLR assistant is the first of its kind in the industry, utilizing secure and responsive AI models to support compliance teams in regulatory reviews. By reducing the complexity of the MLR process, the company seeks to empower biopharma marketers with greater agility while maintaining strict adherence to regulatory guidelines.
The $3.5 million seed funding will accelerate Solstice’s innovation efforts, allowing for further enhancements to the platform’s AI capabilities and expanding its reach within the biopharma sector. Investors Twelve Below and Virtue recognize the potential of the company’s technology to redefine how regulatory compliance and marketing speed can be balanced in the industry.
